Violich Capital Management, Inc. Vertex Pharmaceuticals Inc Transaction History

Violich Capital Management, Inc.

  • $769 Million
  • Q3 2024

Shares

3 transactions
Quarter Operation Price Per share shares change shares Held SEC Form
Q3 2021

Oct 12, 2021
SELL
$181.39 - $202.99 $217,667 - $243,588
-1,200 Closed
0 $0
Q4 2020

Jan 29, 2021
SELL
$207.01 - $276.09 $20,701 - $27,608
-100 Reduced 7.69%
1,200 $284,000
Q1 2020

Apr 30, 2020
BUY
$199.77 - $247.81 $259,701 - $322,153
1,300 New
1,300 $309,000

Others Institutions Holding VRTX

# of Institutions
1,724
Shares Held
222M
Call Options Held
1.58M
Put Options Held
1.36M
View Full List

About VERTEX PHARMACEUTICALS INC

VRTX Quotes by TradingView
  • Ticker VRTX
  • Exchange NASDAQ
  • Sector Healthcare
  • Industry Biotechnology
  • Shares Outstandng 256,691,008
  • Market Cap $119B
  • Description
  • Vertex Pharmaceuticals Incorporated, a biotechnology company, engages in developing and commercializing therapies for treating cystic fibrosis. The company markets SYMDEKO/SYMKEVI, ORKAMBI, and KALYDECO to treat patients with cystic fibrosis who have specific mutations in their cystic fibrosis transmembrane conductance regulator gene; and TRIKAF...
More about VRTX
Track This Portfolio

Track Violich Capital Management, Inc. Portfolio

Follow Violich Capital Management, Inc. and customize your updates to receive the information that matters most to you.

Portfolio Update

Get notified when there are updates to the investment portfolio of Violich Capital Management, Inc., based on Form 13F filings with the SEC.

News

Stay updated on Violich Capital Management, Inc. with notifications on news.

Choose your preferred platform and Sign Up 👇 Telegram Email